AUA Quality Improvement Summit 2014: Conference Proceedings on Infectious Complications of Transrectal Prostate Needle Biopsy

Timothy Averch, Christopher Tessier, J. Quentin Clemens, Michael Franks, Christopher Gonzalez, J. Stephen Jones, Deepak A. Kapoor, Deborah J. Lightner, Michael Liss, James Montie, Richard A. Watson, J. Stuart Wolf

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Introduction: The AUA Quality Improvement Summit is a continuing AUA effort to provide education around issues related to quality improvement and patient safety. Due to the rapidly increasing rates of hospitalization following prostate needle biopsy, Infectious Complications of Transrectal Prostate Needle Biopsy was selected as the inaugural topic. Methods: The information is largely unpublished data provided by the presenting physicians. Infection rates are predominantly self-reported with protocols specified by the physicians' home institutions. Beyond the identified speakers, the open forum of this summit allowed for input from a majority of the participants. Results: Current hospitalization rates for transrectal prostate needle biopsy infections vary widely from 0.5% to 6%. Antibiotic resistance of coliform organisms appears to be a major risk of theseinfectious complications. Prophylactic protocols also vary widely among the represented institutions. Antibiotic resistance profiles showed extreme regional variation and, as such, a prophylactic antibiotic protocol should be based on the current local antibiogram in order to reduce infection rates. Opinions vary in relation to the specific antibiotics appropriate for an augmented antibiotic prophylaxis, in the use of rectal swab and prebiopsy enema, and povidone-iodine preparation of the rectal vault. Standardization of the transrectal antibiotic prophylaxis across practices has been proven to reduce the infectious complications rates. Conclusions: Urologists should monitor the prostate biopsy infection rates of the practice and consult the current local antibiogram. Physicians should query patients to assess whether they are at high risk for resistant organisms. If so, prophylactic protocols might be intensified.

Original languageEnglish (US)
Pages (from-to)172-180
Number of pages9
JournalUrology Practice
Volume2
Issue number4
DOIs
StatePublished - Jul 1 2015
Externally publishedYes

Fingerprint

Needle Biopsy
Quality Improvement
Prostate
Antibiotic Prophylaxis
Microbial Sensitivity Tests
Microbial Drug Resistance
Infection
Physicians
Hospitalization
Anti-Bacterial Agents
Povidone-Iodine
Enema
Patient Safety
Biopsy
Education

Keywords

  • Antibiotic prophylaxis
  • Biopsy
  • Postoperative complications
  • Prostate
  • Sepsis

ASJC Scopus subject areas

  • Urology

Cite this

AUA Quality Improvement Summit 2014 : Conference Proceedings on Infectious Complications of Transrectal Prostate Needle Biopsy. / Averch, Timothy; Tessier, Christopher; Clemens, J. Quentin; Franks, Michael; Gonzalez, Christopher; Jones, J. Stephen; Kapoor, Deepak A.; Lightner, Deborah J.; Liss, Michael; Montie, James; Watson, Richard A.; Wolf, J. Stuart.

In: Urology Practice, Vol. 2, No. 4, 01.07.2015, p. 172-180.

Research output: Contribution to journalArticle

Averch, T, Tessier, C, Clemens, JQ, Franks, M, Gonzalez, C, Jones, JS, Kapoor, DA, Lightner, DJ, Liss, M, Montie, J, Watson, RA & Wolf, JS 2015, 'AUA Quality Improvement Summit 2014: Conference Proceedings on Infectious Complications of Transrectal Prostate Needle Biopsy', Urology Practice, vol. 2, no. 4, pp. 172-180. https://doi.org/10.1016/j.urpr.2014.10.011
Averch, Timothy ; Tessier, Christopher ; Clemens, J. Quentin ; Franks, Michael ; Gonzalez, Christopher ; Jones, J. Stephen ; Kapoor, Deepak A. ; Lightner, Deborah J. ; Liss, Michael ; Montie, James ; Watson, Richard A. ; Wolf, J. Stuart. / AUA Quality Improvement Summit 2014 : Conference Proceedings on Infectious Complications of Transrectal Prostate Needle Biopsy. In: Urology Practice. 2015 ; Vol. 2, No. 4. pp. 172-180.
@article{17f49ba9b54c47b3a440c23be4b71d9d,
title = "AUA Quality Improvement Summit 2014: Conference Proceedings on Infectious Complications of Transrectal Prostate Needle Biopsy",
abstract = "Introduction: The AUA Quality Improvement Summit is a continuing AUA effort to provide education around issues related to quality improvement and patient safety. Due to the rapidly increasing rates of hospitalization following prostate needle biopsy, Infectious Complications of Transrectal Prostate Needle Biopsy was selected as the inaugural topic. Methods: The information is largely unpublished data provided by the presenting physicians. Infection rates are predominantly self-reported with protocols specified by the physicians' home institutions. Beyond the identified speakers, the open forum of this summit allowed for input from a majority of the participants. Results: Current hospitalization rates for transrectal prostate needle biopsy infections vary widely from 0.5{\%} to 6{\%}. Antibiotic resistance of coliform organisms appears to be a major risk of theseinfectious complications. Prophylactic protocols also vary widely among the represented institutions. Antibiotic resistance profiles showed extreme regional variation and, as such, a prophylactic antibiotic protocol should be based on the current local antibiogram in order to reduce infection rates. Opinions vary in relation to the specific antibiotics appropriate for an augmented antibiotic prophylaxis, in the use of rectal swab and prebiopsy enema, and povidone-iodine preparation of the rectal vault. Standardization of the transrectal antibiotic prophylaxis across practices has been proven to reduce the infectious complications rates. Conclusions: Urologists should monitor the prostate biopsy infection rates of the practice and consult the current local antibiogram. Physicians should query patients to assess whether they are at high risk for resistant organisms. If so, prophylactic protocols might be intensified.",
keywords = "Antibiotic prophylaxis, Biopsy, Postoperative complications, Prostate, Sepsis",
author = "Timothy Averch and Christopher Tessier and Clemens, {J. Quentin} and Michael Franks and Christopher Gonzalez and Jones, {J. Stephen} and Kapoor, {Deepak A.} and Lightner, {Deborah J.} and Michael Liss and James Montie and Watson, {Richard A.} and Wolf, {J. Stuart}",
year = "2015",
month = "7",
day = "1",
doi = "10.1016/j.urpr.2014.10.011",
language = "English (US)",
volume = "2",
pages = "172--180",
journal = "Urology Practice",
issn = "2352-0779",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - AUA Quality Improvement Summit 2014

T2 - Conference Proceedings on Infectious Complications of Transrectal Prostate Needle Biopsy

AU - Averch, Timothy

AU - Tessier, Christopher

AU - Clemens, J. Quentin

AU - Franks, Michael

AU - Gonzalez, Christopher

AU - Jones, J. Stephen

AU - Kapoor, Deepak A.

AU - Lightner, Deborah J.

AU - Liss, Michael

AU - Montie, James

AU - Watson, Richard A.

AU - Wolf, J. Stuart

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Introduction: The AUA Quality Improvement Summit is a continuing AUA effort to provide education around issues related to quality improvement and patient safety. Due to the rapidly increasing rates of hospitalization following prostate needle biopsy, Infectious Complications of Transrectal Prostate Needle Biopsy was selected as the inaugural topic. Methods: The information is largely unpublished data provided by the presenting physicians. Infection rates are predominantly self-reported with protocols specified by the physicians' home institutions. Beyond the identified speakers, the open forum of this summit allowed for input from a majority of the participants. Results: Current hospitalization rates for transrectal prostate needle biopsy infections vary widely from 0.5% to 6%. Antibiotic resistance of coliform organisms appears to be a major risk of theseinfectious complications. Prophylactic protocols also vary widely among the represented institutions. Antibiotic resistance profiles showed extreme regional variation and, as such, a prophylactic antibiotic protocol should be based on the current local antibiogram in order to reduce infection rates. Opinions vary in relation to the specific antibiotics appropriate for an augmented antibiotic prophylaxis, in the use of rectal swab and prebiopsy enema, and povidone-iodine preparation of the rectal vault. Standardization of the transrectal antibiotic prophylaxis across practices has been proven to reduce the infectious complications rates. Conclusions: Urologists should monitor the prostate biopsy infection rates of the practice and consult the current local antibiogram. Physicians should query patients to assess whether they are at high risk for resistant organisms. If so, prophylactic protocols might be intensified.

AB - Introduction: The AUA Quality Improvement Summit is a continuing AUA effort to provide education around issues related to quality improvement and patient safety. Due to the rapidly increasing rates of hospitalization following prostate needle biopsy, Infectious Complications of Transrectal Prostate Needle Biopsy was selected as the inaugural topic. Methods: The information is largely unpublished data provided by the presenting physicians. Infection rates are predominantly self-reported with protocols specified by the physicians' home institutions. Beyond the identified speakers, the open forum of this summit allowed for input from a majority of the participants. Results: Current hospitalization rates for transrectal prostate needle biopsy infections vary widely from 0.5% to 6%. Antibiotic resistance of coliform organisms appears to be a major risk of theseinfectious complications. Prophylactic protocols also vary widely among the represented institutions. Antibiotic resistance profiles showed extreme regional variation and, as such, a prophylactic antibiotic protocol should be based on the current local antibiogram in order to reduce infection rates. Opinions vary in relation to the specific antibiotics appropriate for an augmented antibiotic prophylaxis, in the use of rectal swab and prebiopsy enema, and povidone-iodine preparation of the rectal vault. Standardization of the transrectal antibiotic prophylaxis across practices has been proven to reduce the infectious complications rates. Conclusions: Urologists should monitor the prostate biopsy infection rates of the practice and consult the current local antibiogram. Physicians should query patients to assess whether they are at high risk for resistant organisms. If so, prophylactic protocols might be intensified.

KW - Antibiotic prophylaxis

KW - Biopsy

KW - Postoperative complications

KW - Prostate

KW - Sepsis

UR - http://www.scopus.com/inward/record.url?scp=84937632839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937632839&partnerID=8YFLogxK

U2 - 10.1016/j.urpr.2014.10.011

DO - 10.1016/j.urpr.2014.10.011

M3 - Article

AN - SCOPUS:84937632839

VL - 2

SP - 172

EP - 180

JO - Urology Practice

JF - Urology Practice

SN - 2352-0779

IS - 4

ER -